Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in Spain

NCT ID: NCT00881881

Last Updated: 2009-04-15

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 360 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2006-12-31
• Study Completion Date: 2007-04-30

Brief Summary

This is an epidemiological, multicenter, retrospective study to analyze the management of rheumatoid arthritis (RA) in usual clinical practice in Spain. Two groups of patients will be analyzed: individuals who have had RA for two years or less (the "early RA" group) and individuals who have had RA for more than 2 years and who currently meet the ACR criteria for RA (the "established RA" group).

Conditions

Rheumatoid Arthritis

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Study Groups

1

Patients with early RA

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• Group 1: early RA : patients with disease lasting 2 years or less, considered by the investigator as an early RA
• Group 2: established RA: patients with disease lasting more than 2 years who meet the ACR criteria for RA

Exclusion Criteria

• Patients with any rheumatic disease different from RA
• Participation in any clinical trial or study in the last 12 months

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

Sponsor Role: lead

Responsible Party

Wyeth

Principal Investigators

Medical Monitor

Role: STUDY_DIRECTOR

Wyeth is now a wholly owned subsidiary of Pfizer

Other Identifiers

0881A-102388

Identifier Type: -

Identifier Source: org_study_id